Latest Drug Approvals news
.jpg)
FDA Approves Imfinzi for Early Gastric and Gastroesophageal Cancers
posted December 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines
posted November 19th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Darzalex Faspro for High-Risk Smoldering Multiple Myeloma
posted November 13th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Caplyta for Major Depressive Disorder in Adults
posted November 13th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Maternal Night-Shift Work Tied to Later Neurodevelopmental Issues in Offspring 
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers Related Articles
Most Speakers at FDA Advisory Committee Meetings Support Drug Approval 
FDA Picks George Tidmarsh to Head Center for Drug Evaluation and Research 
Approved-Label Populations for New Drugs Broader Than Trial Populations Monthly Specialist Briefings
Stay Connected
